Migraines affect millions of people in the United States. According to the American Migraine Foundation, it’s the third most common disease in the world. But now, a new study found people who suffer from migraines might be able to predict when one is coming hours before symptoms even start.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

One in 50 children in the United States is allergic to peanuts, while 1 in 200 adults have the allergy, too. Peanut allergies have more than tripled over the past 20 years, and nobody really knows why.

But, there are several breakthroughs when it comes to helping people with these allergies stay safe – maybe even one day, be able to eat whatever they like without the fear of an allergic reaction.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It has been found that inhibition of a specific brain enzyme can be therapeutic in animal models of stroke, epilepsy, neuropathic pain, and Lou Gehrig’s disease. Unfortunately, these drugs have poor penetration into the brain, which has hampered their clinical development. Now, there is new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.